Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 3:668-672 (2006)
© 2006 The American Thoracic Society
doi: 10.1513/pats.200605-122SF

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warburton, D.
Right arrow Articles by Shi, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warburton, D.
Right arrow Articles by Shi, W.

Lung Development and Susceptibility to Chronic Obstructive Pulmonary Disease

David Warburton, Jack Gauldie, Saverio Bellusci and Wei Shi

Developmental Biology Program, Saban Research Institute, Children's Hospital–Los Angeles; Keck School of Medicine and School of Dentistry, University of Southern California, Los Angeles, California; and Centre for Gene Therapeutics, McMaster University, Hamilton, Ontario, Canada

Correspondence and requests for reprints should be addressed to David Warburton, M.D., D.Sc., F.R.C.P., F.R.C.S., Developmental Biology Program, Saban Research Institute Children's Hospital–Los Angeles, 4650 Sunset Blvd. #35, Los Angeles, CA 90027. E-mail: dwarburton{at}chla.usc.edu

ABSTRACT

Chronic obstructive pulmonary disease with emphysema has been considered to be an accelerated involutional disease of aging smokers. However, because only a proportion (~ 15%) of smokers develop chronic obstructive pulmonary disease with emphysema, clearly genetic susceptibility must play a significant part in determining both the age of onset and the rapidity of decline in lung function. In mice, interference with key genes, either by null mutation, hypomorphism, or gain or loss of function, results in phenotypes comprising either neonatal lethal respiratory distress if the structural effect is severe, or reduced alveolarization and/or early-onset emphysema if the effect is milder. Likewise, null mutants that interfere with matrix assembly and/or integrity, such as elastin, lysyl oxidase, or fibrillin, also result in alveolar dysplasia. Importantly, null mutation of Smad3, which encodes a receptor-activated Smad in the transforming growth factor-ß signaling pathway, results in a more subtle failure to correctly organize the alveolar matrix, which is in turn antecedent to early-onset emphysema mediated by matrix metalloproteinase-9. Furthermore, exposure to side-stream smoke profoundly exacerbates and accelerates alveolar destruction, leading to more severe early-onset emphysema in young Smad3-null mice (unpublished data). Interestingly, polymorphisms in the fibrillin, transforming growth factor-ß type II receptor, and matrix metalloproteinase-9 genes have been described in humans with emphysema. Thus, dysplastic or degraded matrix cannot provide the structural niche for alveolar stem/progenitor cells to assume the correct phenotype and/or repair the alveolar cell lineage niche. The hope is that providing the correct exogenous signals can coax them into doing so.

Key Words: lung development • disease susceptibility genes • chronic obstructive pulmonary disease




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
D. Warburton, L. Perin, R. DeFilippo, S. Bellusci, W. Shi, and B. Driscoll
Stem/Progenitor Cells in Lung Development, Injury Repair, and Regeneration
Proceedings of the ATS, August 15, 2008; 5(6): 703 - 706.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Chen, F. Zhuang, Y-H. Liu, B. Xu, P. del Moral, W. Deng, Y. Chai, M. Kolb, J. Gauldie, D. Warburton, et al.
TGF-{beta} receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung
Eur. Respir. J., August 1, 2008; 32(2): 285 - 295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Sun, H. Chen, C. Chen, J. A. Whitsett, Y. Mishina, P. Bringas Jr., J. C. Ma, D. Warburton, and W. Shi
Prenatal Lung Epithelial Cell-Specific Abrogation of Alk3-Bone Morphogenetic Protein Signaling Causes Neonatal Respiratory Distress by Disrupting Distal Airway Formation
Am. J. Pathol., March 1, 2008; 172(3): 571 - 582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.